Breaking News Instant updates and real-time market news.

AMGN

Amgen

$185.60

-0.69 (-0.37%)

, SCR

Simcere

16:03
09/26/17
09/26
16:03
09/26/17
16:03

Amgen and Simcere execute agreement to co-develop four biosimilars in China

Amgen (AMGN) and Simcere Pharmaceutical Group (SCR) announced the execution of an exclusive agreement to co-develop and commercialize four biosimilars in China. The collaboration includes undisclosed biosimilars in the areas of inflammation and oncology. Under the terms of the agreement, Amgen will remain responsible for the co-development, marketing approval applications and manufacturing of the biosimilars. Simcere will be responsible for distribution and commercialization in China, while Amgen will have a limited right to co-promote the products. The biosimilars included in the agreement are a part of Amgen's existing biosimilars portfolio. Specific financial terms of the agreement were not disclosed.

AMGN

Amgen

$185.60

-0.69 (-0.37%)

SCR

Simcere

  • 08

    Nov

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

AMGN Amgen
$185.60

-0.69 (-0.37%)

09/07/17
PIPR
09/07/17
NO CHANGE
Target $557
PIPR
Overweight
Regeneron selloff today a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff notes shares of Regeneron Pharmaceuticals (REGN) are trading lower after Phase IIb readouts from competitors Amgen (AMGN) and AstraZeneca (AZN) in asthma and AbbVie (ABBV) in atopic dermatitis met their primary endpoints. The analyst does not see an "immediate competitive threat" to Regeneron's Dupixent, which he says has successfully launched in atopic dermatitis following FDA approval in March. He recommends buying the shares on today's selloff ahead of expected "positive" Phase III Dupixent asthma data. Dupixent maintains at least a two-year lead ahead of these competitive agents, Tenthoff tells investors in an intraday research note. The analyst reiterates an Overweight rating on Regeneron with a $557 price target.
09/14/17
RBCM
09/14/17
INITIATION
Target $192
RBCM
Sector Perform
Amgen initiated with a Sector Perform at RBC Capital
RBC Capital analyst Kennen MacKay initiated Amgen with a Sector Perform and an $192 price target.
09/21/17
UBSW
09/21/17
NO CHANGE
Target $500
UBSW
Buy
Regeneron price target lowered to $500 from $535 at UBS
UBS analyst Carter Gould lowered his price target on Regeneron (REGN) to $500 from $535 citing increased Dupixent competition after Amgen (AMGN) and AstraZeneca (AZN) reported data on their own asthma drug earlier this month and AbbVie (ABBV) reported results in an atopic dermatitis study. While he noted that definitive 12-month phase 3 data from these competitors is likely more than 20 months away, he also lowered his Dupixent peak sales estimate to $4.8B from $6.5B. He keeps a Buy rating on Regeneron shares, as he believes pipeline products including nesvacumab and REGN2810 offer a path to longer-term upside.
09/25/17
JEFF
09/25/17
NO CHANGE
Target $200
JEFF
Buy
Jefferies explains how Amgen can re-rate higher like AbbVie
Jefferies analyst Michael Yee believes the 2018-2020 consensus estimates for Amgen (AMGN) may be too low if Mylan's (MYL) biosimilar of Neulasta doesn't get approved next month. The Biosimilar User Fee Act date is October 9. Investors may become more confident in the durability of Amgen's franchise given that AbbVie (ABBV) defended Humira and re-rated to a higher valuation, Yee tells investors in a research note. The key issue keeping Amgen's price-to-earnings multiple below peers at 12 to 13 times over the past couple of years is investor fear of biosimilars primarily against Neulasta and Enbrel, Yee argues. He sees a failed approval for Mylan as setting the tone for a higher multiple like AbbVie. The analyst has a Buy rating on Amgen shares with a $200 price target.
SCR Simcere

TODAY'S FREE FLY STORIES

DKL

Delek Logistics

$31.15

-0.35 (-1.11%)

, GPP

Green Plains Partners

$18.00

0.2 (1.12%)

08:20
02/20/18
02/20
08:20
02/20/18
08:20
Hot Stocks
Delek Logistics, Green Plains Partners announce formation of logistics JV »

Delek Logistics Partners…

DKL

Delek Logistics

$31.15

-0.35 (-1.11%)

GPP

Green Plains Partners

$18.00

0.2 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

YUM

Yum! Brands

$78.25

-0.72 (-0.91%)

08:20
02/20/18
02/20
08:20
02/20/18
08:20
Periodicals
Yum's KFC U.K. restaurants facing chicken shortage, shutting branches, FT says »

Yum's KFC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$189.34

-0.7 (-0.37%)

08:20
02/20/18
02/20
08:20
02/20/18
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRGO

Perrigo

$89.55

-0.1 (-0.11%)

08:20
02/20/18
02/20
08:20
02/20/18
08:20
Hot Stocks
Perrigo confirms patent challenge with FDA for generic version of Finacea Foam »

Perrigo Company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

XLK

Technology Select Sector SPDR

$67.18

-0.1 (-0.15%)

08:19
02/20/18
02/20
08:19
02/20/18
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$224.19

-1.21 (-0.54%)

, CSRA

CSRA

$40.56

0.04 (0.10%)

08:19
02/20/18
02/20
08:19
02/20/18
08:19
Recommendations
General Dynamics, CSRA analyst commentary  »

General Dynamics price…

GD

General Dynamics

$224.19

-1.21 (-0.54%)

CSRA

CSRA

$40.56

0.04 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

EEM

MSCI Emerging Markets Index

$49.54

-0.16 (-0.32%)

08:19
02/20/18
02/20
08:19
02/20/18
08:19
Technical Analysis
Technical Take: MSCI Emerging Markets ETF falls in early trading »

The MSCI Emerging Markets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$68.12

-0.17 (-0.25%)

08:19
02/20/18
02/20
08:19
02/20/18
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$104.79

-0.51 (-0.48%)

08:19
02/20/18
02/20
08:19
02/20/18
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$60.48

-0.22 (-0.36%)

08:19
02/20/18
02/20
08:19
02/20/18
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDRBF

Bombardier

$2.96

0.024 (0.82%)

08:18
02/20/18
02/20
08:18
02/20/18
08:18
Upgrade
Bombardier rating change  »

Bombardier upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$50.12

0.44 (0.89%)

08:18
02/20/18
02/20
08:18
02/20/18
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLNT

Planet Fitness

$32.38

-0.05 (-0.15%)

08:18
02/20/18
02/20
08:18
02/20/18
08:18
Recommendations
Planet Fitness analyst commentary  »

Planet Fitness price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

XLP

Consumer Staples Sector SPDR

$55.60

0.22 (0.40%)

08:18
02/20/18
02/20
08:18
02/20/18
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$85.41

0.61 (0.72%)

08:18
02/20/18
02/20
08:18
02/20/18
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAH

Cardinal Health

$69.34

1.24 (1.82%)

08:18
02/20/18
02/20
08:18
02/20/18
08:18
Periodicals
Cardinal accused by Kentucky AG of contributing to opioid epidemic, Reuters says »

Cardinal Health has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 05

    Mar

STLD

Steel Dynamics

$49.40

2.26 (4.79%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Hot Stocks
Steel Dynamics raises dividend 21% to 18.75c »

Steel Dynamics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$153.34

0.54 (0.35%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLNO

Soleno Therapeutics

$1.62

-0.11 (-6.36%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Hot Stocks
Soleno Therapeutics announces successful end-of-Phase II meeting with FDA »

Soleno Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$251.96

0.11 (0.04%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSBC

HSBC

$53.83

0.08 (0.15%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Technical Analysis
Technical Take: HSBC falls after results »

In pre-market trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

SPY

SPDR S&P 500 ETF Trust

$273.11

0.08 (0.03%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$28.98

-0.04 (-0.14%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTCT

PTC Therapeutics

$23.93

-0.58 (-2.37%)

08:16
02/20/18
02/20
08:16
02/20/18
08:16
Hot Stocks
PTC Therapeutics: FDA's OND denies PTC's appeal of CRL on NDA for ataluren »

PTC Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

SMH

Market Vectors Semiconductor

$102.79

-0.22 (-0.21%)

08:16
02/20/18
02/20
08:16
02/20/18
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.